Search Results | Blood | American Society of Hematology

1-20 of 3649

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Recombinant Factor VIII Fc Fusion Protein for First-time Immune Tolerance Induction: Final Results of the verITI-8 Study

Lynn Daniel Malec, An Van Damme, Anthony KC Chan, Mariya Spasova, Nisha Jain, Charlotte Sensinger, Jennifer Dumont, Stefan Lethagen, Manuel Carcao, Flora Peyvandi

Blood blood.2022017780.

DOI: https://doi.org/10.1182/blood.2022017780

Published: 2023

Includes: Supplemental data

Journal Articles

Effective treatment of low-risk acute GVHD with itacitinib monotherapy

Blood (2023) 141 (5): 481–489.

DOI: https://doi.org/10.1182/blood.2022017442

Published: 2023

Includes: Supplemental data

Journal Articles

NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol

Michael Svaton, Aneta Skotnicova, Leona Reznickova, Andrea Rennerova, Tatana Valova, Michaela Kotrova, Vincent H. J. van der Velden, Monika Brüggemann, Nikos Darzentas, Anton W. Langerak, Jan Zuna, Jan Stary, Jan Trka, Eva Fronkova

Blood (2023) 141 (5): 529–533.

DOI: https://doi.org/10.1182/blood.2022017003

Published: 2023

Includes: Supplemental data

Journal Articles

Delayed normalisation of ADAMTS13 activity in acute Thrombotic Thrombocytopenic Purpura in the caplacizumab era

Nithya Prasannan, Mari Thomas, Matthew James Stubbs, John-Paul Westwood, Rens de Groot, Deepak Singh, Marie Scully

Blood blood.2022018847.

DOI: https://doi.org/10.1182/blood.2022018847

Published: 2023

Includes: Supplemental data

Journal Articles

Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease

Monica L. Hulbert, Melanie E. Fields, Kristin P. Guilliams, Priyesha Bijlani, Shalini Shenoy, Slim Fellah, Alison S. Towerman, Michael M. Binkley, Robert C. McKinstry, Joshua S. Shimony, Yasheng Chen, Cihat Eldeniz, Dustin K. Ragan, Katie Vo, Hongyu An, Jin-Moo Lee, Andria L. Ford

Blood (2023) 141 (4): 335–344.

DOI: https://doi.org/10.1182/blood.2022016618

Published: 2023

Includes: Supplemental data

Journal Articles

Revisiting coexisting chromosomal abnormalities in NPM1 -mutated AML in light of the revised ELN 2022 classification

Linus Angenendt, Christoph Röllig, Pau Montesinos, Farhad Ravandi, Gunnar Juliusson, Christian Récher, Raphaël Itzykson, Zdeněk Ráčil, Andrew H. Wei, Christoph Schliemann

Blood (2023) 141 (4): 433–435.

DOI: https://doi.org/10.1182/blood.2022018582

Published: 2023

Journal Articles

An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML

Blood (2023) 141 (3): 295–308.

DOI: https://doi.org/10.1182/blood.2022016916

Published: 2023

Includes: Supplemental data

Journal Articles

Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy

Andrew J. Doyle, Matthew J. Stubbs, Tina Dutt, Will Lester, Will Thomas, Joost van Veen, Joannes Hermans, Tanya Cranfield, Quentin A. Hill, Amanda Clark, Catherine Bagot, Steven Austin, John-Paul Westwood, Mari Thomas, Marie Scully

Blood (2023) 141 (3): 285–294.

DOI: https://doi.org/10.1182/blood.2022017023

Published: 2023

Journal Articles

Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents

Blood (2023) 141 (3): 219–230.

DOI: https://doi.org/10.1182/blood.2022015526

Published: 2023

Includes: Supplemental data

Journal Articles

High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients

Blood (2023) 141 (3): 309–314.

DOI: https://doi.org/10.1182/blood.2022017439

Published: 2023

Includes: Supplemental data

Journal Articles

A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis

Carlton D. Dampier, Marilyn Jo Telen, Ted Wun, R. Clark Brown, Payal Desai, Fuad El Rassi, Beng Fuh, Julie Kanter, Yves Pastore, Jennifer Rothman, James G. Taylor, VI, David Readett, Krupa M. Sivamurthy, Brinda Tammara, Li-Jung Tseng, Jay Nelson Lozier, Helen Thackray, John L. Magnani, Kathryn L. Hassell

Blood (2023) 141 (2): 168–179.

DOI: https://doi.org/10.1182/blood.2022015797

Published: 2023

Includes: Supplemental data

Journal Articles

Ups and downs in the treatment of sickle cell disease

Valentine Brousse

Blood (2023) 141 (2): 125–127.

DOI: https://doi.org/10.1182/blood.2022018075

Published: 2023

Journal Articles

Enasidenib vs conventional care in older patients with late-stage mutant- IDH2 relapsed/refractory AML: a randomized phase 3 trial

Blood (2023) 141 (2): 156–167.

DOI: https://doi.org/10.1182/blood.2021014901

Published: 2023

Includes: Supplemental data

Journal Articles

Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies

James A. Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, Kelly J. Gaffney, Mary McGann, Alyssa Cendagorta, Aswani Thurlapati, Amanda Herbst, Lindsey Hendrickson, Hamza Hashmi, Brian T. Hess

Blood (2023) 141 (2): 200–203.

DOI: https://doi.org/10.1182/blood.2022018283

Published: 2023

Journal Articles

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the Phase 3 POLARIX trial

Blood blood.2022017734.

DOI: https://doi.org/10.1182/blood.2022017734

Published: 2023

Includes: Supplemental data

Journal Articles

Rare Germline Complement Factor H Variants in Patients with Paroxysmal Nocturnal Hemoglobinuria

Pedro Henrique Prata, Jacques-Emmanuel Galimard, Flore Sicre de Fontbrune, Anna Duval, Paula Vieira-Martins, Stephane Roncelin, Pierre-Edouard Debureaux, Anne Claire Lepretre, Lise Larcher, Rudy Birsen, Ygal Benhamou, Jean Soulier, Gérard Socie, Véronique Fremeaux-Bacchi, Régis Peffault de Latour

Blood blood.2022017019.

DOI: https://doi.org/10.1182/blood.2022017019

Published: 2023

Includes: Supplemental data

Journal Articles

A phase II clinical trial of combined BRAF/MEK inhibition for BRAF V600E -mutated multiple myeloma

Blood blood.2022017789.

DOI: https://doi.org/10.1182/blood.2022017789

Published: 2023

Includes: Supplemental data

Journal Articles

Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity

Blood (2023) 141 (1): 60–71.

DOI: https://doi.org/10.1182/blood.2022015482

Published: 2023

Includes: Supplemental data

Journal Articles

Experience of compassionate-use pegcetacoplan for paroxysmal nocturnal hemoglobinuria

Morag Griffin, Petra Muus, Talha Munir, Sateesh Nagumantry, Alexandra Pike, Louise Arnold, Briony Forrest, Catherine Barnfield, Nicola Houghton, Nora Youngs, Richard Kelly

Blood (2023) 141 (1): 116–120.

DOI: https://doi.org/10.1182/blood.2022017266

Published: 2023

Journal Articles

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study

Blood (2023) 141 (1): 11–21.

DOI: https://doi.org/10.1182/blood.2022017277

Published: 2023

Includes: Supplemental data

2 3 4 5

NARROW

Recombinant Factor VIII Fc Fusion Protein for First-time Immune Tolerance Induction: Final Results of the verITI-8 Study

Effective treatment of low-risk acute GVHD with itacitinib monotherapy

NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol

Delayed normalisation of ADAMTS13 activity in acute Thrombotic Thrombocytopenic Purpura in the caplacizumab era

Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease

Revisiting coexisting chromosomal abnormalities in NPM1 -mutated AML in light of the revised ELN 2022 classification

An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML

Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy

Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents

High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients

A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis

Ups and downs in the treatment of sickle cell disease

Enasidenib vs conventional care in older patients with late-stage mutant- IDH2 relapsed/refractory AML: a randomized phase 3 trial

Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the Phase 3 POLARIX trial

Rare Germline Complement Factor H Variants in Patients with Paroxysmal Nocturnal Hemoglobinuria

A phase II clinical trial of combined BRAF/MEK inhibition for BRAF V600E -mutated multiple myeloma

Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity

Experience of compassionate-use pegcetacoplan for paroxysmal nocturnal hemoglobinuria

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only